Population Pharmacokinetics and Exposure‐Response Analyses for CPX‐351 in Patients With Hematologic Malignancies

nork Wang, Qi, Banerjee, Kamalika, Vasilinin, Grygoriy, Marier, J.F., Gibbons, Jacqueline A.
Argitaratua izan da J Clin Pharmacol (2018)

Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage

nork Edwards, JE, LaCerte, C, Peyret, T, Gosselin, NH, Marier, JF, Hofmann, AF, Shapiro, D
Argitaratua izan da Clin Transl Sci (2016)

Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate()

nork Lichter-Konecki, Uta, Diaz, G.A., Merritt, J.L., Feigenbaum, A., Jomphe, C., Marier, J.F., Beliveau, M., Mauney, J., Dickinson, K., Martinez, A., Mokhtarani, M., Scharschmidt, B., Rhead, W.
Argitaratua izan da Mol Genet Metab (2011)

Phase 2 Comparison of A Novel Ammonia Scavenging Agent With Sodium Phenylbutyrate In Patients With Urea Cycle Disorders: Safety, Pharmacokinetics And Ammonia Control

nork Lee, Brendan, Rhead, William, Diaz, George A., Scharschmidt, Bruce F., Mian, Asad, Shchelochkov, Oleg, Marier, JF, Beliveau, Martin, Mauney, Joseph, Dickinson, Klara, Martinez, Antonia, Gargosky, Sharron, Mokhtarani, Masoud, Berry, Susan A.
Argitaratua 2010